Drug intelligence / Profile preview

Xin Yin pill

Development stage: Unknown
Lead developer: First Affiliated Hospital of Guangzhou University of Chinese Medicine
Administration: Oral

Overview

Xin Yin pill is a Traditional Chinese Medicine (TCM) formulation developed by The First Affiliated Hospital of Guangzhou University of TCM for the treatment of chronic heart failure (CHF). It is specifically designed for patients presenting with the TCM syndrome of Qi and Yin deficiency accompanied by blood stasis and water retention. In clinical research, it is often evaluated as an adjunctive therapy to optimized Western medical treatment. The formulation aims to improve cardiac function and alleviate symptoms by tonifying Qi, nourishing Yin, promoting blood circulation, and facilitating diuresis to resolve edema.

Other names: Xin Yin Pill

Beyond the preview

Go deeper on Xin Yin pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xin Yin pill.

Explore the full profile